UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE13-A16 OR 15D-16 UNDER
The SECURITIES EXCHANGE ACT OF 1934
For the Month of December, 2021
Commission File Number: 001-40010
Pharvaris N.V.
(Translation of registrant’s name into English)
J.H. Oortweg 21
2333 CH Leiden
The Netherlands
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
PHARVARIS N.V.
Effective December 1, 2021, Martijn Kleijwegt voluntarily resigned as a director of the Board of Directors (“the Board”) of Pharvaris N.V. (the “Company”). Mr. Kleijwegt’s resignation from the Board was not due to any disagreement with the Company.
On December 1, 2021, by a special resolution of the Board, Elisabeth Björk was designated as non-executive director of the Company, expected to be confirmed at the Company’s 2022 annual general meeting of shareholders.
On December 7, 2021, the Company issued a press release related to the forgoing matters. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PHARVARIS N.V. | ||||||
Date: December 7, 2021 | By: | /s/ Berndt Modig | ||||
Name: | Berndt Modig | |||||
Title: | Chief Executive Officer |
4